DURECT Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| PFE | Pfizer | Outperform |
2
|
$28.64 | $32.87 | 6.49% | 6 | $162.29B |
| TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$16.29 | $11.59 | 4.36% | 9 | $18.45B |
| VTRS | Viatris Inc | Hold |
8
|
$10.98 | $11.73 | 9.29% | 5 | $13.32B |
| SUPN | Supernus Pharmaceuticals | Outperform |
16
|
$29.10 | $41.00 | 40.89% | 0 | $1.72B |
| COPN | Cosmo Pharmaceuticals N.V. | Buy |
12
|
CHF72.90 | CHF76.55 | 28.34% | 0 | CHF1.14B |
| COLL | Collegium Pharmaceutical | Outperform |
11
|
$32.47 | $37.75 | 23.19% | 1 | $1.24B |
| ZVRA | Zevra Therapeutics | Buy |
10
|
$4.73 | $19.50 | 291.12% | 1 | $204.66M |
| CPIX | Cumberland Pharmaceuticals | - |
0
|
$2.03 | $8.50 | -100.00% | 0 | $24.38M |
| ACRX | AcelRx Pharmaceuticals | Outperform |
6
|
$1.08 | $4.63 | 293.52% | 0 | $17.33M |
| DMK | DMK Pharmaceuticals | - |
8
|
$0.03 | $1.50 | -100.00% | 0 | $0.35M |